Board of Span Divergent approves investment in Quest Biochemicals
At meeting held on 21 November 2017
The Board of Span Divergent has approved making investment in Quest Biochemicals subject to prerequisite approvals / conditions as may be required.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content